| |
| |
|
| Insider
Information: |
Gline Matthew |
| Relationship: |
|
| City: |
London |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,153,706 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,129,174 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,153,706 |
|
|
| Total
Value |
$13,129,174 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Roivant Sciences Ltd. |
ROIV |
|
2024-04-20 |
1,153,706 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2024-04-20 |
4 |
D |
$10.46 |
$114,485 |
D/D |
(10,945) |
1,153,706 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2024-03-30 |
4 |
D |
$10.54 |
$2,276,545 |
D/D |
(215,991) |
1,164,651 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2024-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
390,579 |
1,380,642 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2024-03-20 |
4 |
D |
$10.01 |
$109,559 |
D/D |
(10,945) |
990,063 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2024-02-20 |
4 |
D |
$11.54 |
$126,305 |
D/D |
(10,945) |
1,001,008 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2024-01-20 |
4 |
D |
$10.35 |
$113,281 |
D/D |
(10,945) |
1,011,953 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-12-27 |
4 |
D |
$11.58 |
$255,258 |
D/D |
(22,043) |
1,022,898 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,453 |
1,044,941 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-12-20 |
4 |
D |
$9.96 |
$109,012 |
D/D |
(10,945) |
1,006,488 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-11-22 |
4 |
AS |
$8.68 |
$98,240 |
D/D |
(11,318) |
1,017,433 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-10-24 |
4 |
AS |
$8.99 |
$112,276 |
D/D |
(12,489) |
1,028,751 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-09-28 |
4 |
D |
$12.67 |
$129,779 |
D/D |
(10,243) |
1,041,240 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-09-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,762 |
1,051,483 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-09-22 |
4 |
AS |
$10.19 |
$114,403 |
D/D |
(11,227) |
1,033,721 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-08-28 |
4 |
D |
$11.25 |
$76,320 |
D/D |
(6,784) |
1,044,948 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-08-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,088 |
1,051,732 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-08-22 |
4 |
AS |
$10.83 |
$119,292 |
D/D |
(11,015) |
1,039,644 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-08-02 |
4 |
D |
$11.79 |
$138,521 |
D/D |
(11,749) |
1,050,659 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-07-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,149 |
1,062,408 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-07-24 |
4 |
AS |
$10.99 |
$122,495 |
D/D |
(11,146) |
1,039,259 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-06-22 |
4 |
AS |
$10.01 |
$108,739 |
D/D |
(10,863) |
1,050,405 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-05-31 |
4 |
D |
$9.09 |
$275,118 |
D/D |
(30,266) |
1,061,268 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
53,281 |
1,091,534 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-05-23 |
4 |
AS |
$9.58 |
$181,752 |
D/D |
(18,972) |
1,038,253 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-04-20 |
4 |
D |
$8.80 |
$170,500 |
D/D |
(19,375) |
1,057,225 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
